|Articles|September 3, 2019
N-1 Bioreactor Perfusion Capability
Author(s)Samsung Biologics
Related Content
Trending on Pharmaceutical Technology
1
Mature Medicines Divestment Signals Shift in Manufacturing Strategy
2
CPHI Milan 2026: AI and Bioavailability, Part 1
3
Driving Quality Culture to Manage Risk: Lessons from an FDA Inspection Response
4
The Risk File Was Never Meant to Be a Once-a-Year Exercise
5